These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.

Tryngolza package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

TRYNGOLZA® (olezarsen) is an FDA-approved treatment in adults with FCS as an adjunct to diet. See Safety & Full Prescribing Information.

Dec 19, 2025 · Table of Contents Tryngolza Product Label The following document was submitted to the FDA by the labeler of this product Ionis Pharmaceuticals, Inc.. The document includes …

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information …

Do not use TRYNGOLZA if: • you have had a serious allergic reaction to olezarsen or any of the ingredients in TRYNGOLZA. See the end of this Patient Information for a complete list of …

Medscape - Familial chylomicronemia syndrome (FCS) dosing for Tryngolza (olezarsen), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & …

The safety of TRYNGOLZA was evaluated in 66 patients with FCS enrolled in Trial 1 (NCT #04568434) [see Clinical Studies (14)] . In this trial, 43 patients received at least one dose of …

Jan 15, 2025 · DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? TRYNGOLZA is a prescription medicine (an APOC-III-directed antisense oligonucleotide) that is used along with …

Feb 4, 2025 · TRYNGOLZA is contraindicated in patients with a history of serious hypersensitivity to olezarsen or any of the excipients in TRYNGOLZA. Hypersensitivity reactions, including …